Poster-Quality of Life and Outcomes
October 25, 2021
Multiple Sclerosis, Cognition and the Ability to Participate in Social Roles and Activities: Disease Impact Beyond Physical Disability
Background: Multiple Sclerosis is central demyelinating disease that often results in visible motor and coordination or ambulation impact...
Poster-Quality of Life and Outcomes
October 25, 2021
Multiple Sclerosis and the Ability to Participate in Social Roles and Activities: Disease Impact Beyond Physical Disability
Background: Multiple Sclerosis is a central demyelinating disease that often results in visible motor and coordination or ambulation impact...
October 25, 2021
Multiple Sclerosis, Patient Reported Meaning and Purpose: The Relationship of Physical Ability to Patient Reported Quality of Life
Background: Multiple Sclerosis (MS) is an autoimmune disease characterized by relapses, progression, physical disability and MRI changes....
Poster-Disease-modifying Therapy
October 25, 2021
Real-Life Experience with Ocrelizumab in Older Patients at an Academic MS Center
Background: Ocrelizumab (OCR) is a B-Cell depleting humanized monoclonal antibody FDA-approved for treatment of relapsing remitting...
Poster-Disease-modifying Therapy
October 25, 2021
Analysis of Health Care Provider Reasons for Switching to Diroximel Fumarate from Other Disease-Modifying Therapies
Background: Switching of disease-modifying therapies (DMTs) for treatment of multiple sclerosis (MS) is driven by many factors that are not...
October 25, 2021
Association between Cognition and Social Role Participation Among Patients with Multiple Sclerosis
Background: Multiple sclerosis (MS), a relapsing and progressive demyelinating disease of the central nervous system, results in impaired...